Coeptis Therapeutics Holdings, Inc. — Form D
Coeptis Therapeutics Holdings, Inc. of WEXFORD, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-03. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-11-03
- Form: D
- Accession: 0001759186-23-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $2.0M
- Investors: 1
- Date of first sale: 2023-10-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-496455
Issuer
- Name: Coeptis Therapeutics Holdings, Inc.
- CIK: 0001759186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 105 BRADFORD ROAD, WEXFORD, PA, 15090
- Phone: 724-934-6467
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Brian Cogley | Executive Officer | Cranberry Twp, PA |
| David Mehalick | Director | Naples, FL |
| David Mehalick | Executive Officer | Naples, FL |
| Christopher Cochran | Director | Wexford, PA |
| Christopher Calise | Director | Wexford, PA |
| Tara Maria DeSilva | Director | Wexford, PA |
| Daniel Yerace | Director | Wexford, PA |
| Daniel Yerace | Executive Officer | Wexford, PA |
| Gene Maria Salkind | Director | Wexford, PA |
| Philippe Maria Deschamps | Director | Wexford, PA |
| Christopher Maria Cochran | Director | Wexford, PA |
| Colleen Delaney | Executive Officer | Wexford, PA |
| Christine Sheehy | Executive Officer | Wexford, PA |
Other filings by this issuer (2)
More